1. Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
   Yiwu Yao et al, 2015, J. Med. Chem. CrossRef
2. Structural and Functional Influence of the Glycine-Rich Loop G302GGGY on the Catalytic Tyrosine of Histone Deacetylase 8
   Nicholas J. Porter et al, 2016, Biochemistry CrossRef
3. Annexin Proteins: Novel Promising Targets for Anticancer Drug Development
   Filiz Bakar, 2017 CrossRef
4. Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
   Maria Mrakovcic et al, 2017, IJMS CrossRef
5. Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
   Maria Mrakovcic et al, 2018, IJMS CrossRef
6. p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
   Maria Mrakovcic et al, 2019, IJMS CrossRef
7. Suppression of Histone Deacetylases Worsens Right Ventricular Dysfunction after Pulmonary Artery Banding in Rats
   Harm J. Bogaard et al, 2011, Am J Respir Crit Care Med CrossRef
8. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
   Simone Moertl et al, 2019, IJMS CrossRef
9. Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer
   null Sánchez-Álvarez et al, 2019, Cancers CrossRef
10. Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications.
    David S Schrump, 2009, Clin. Cancer Res. CrossRef
11. Association between the antioxidant properties of SESN proteins and anti-cancer therapies
    Joanna Kozak et al, 2023, Amino Acids CrossRef
12. A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS—Like Zebrafish Model
    Maximilian Schindler et al, 2023, JASN CrossRef